Your browser doesn't support javascript.
loading
Evaluation of physician guideline adherence and areas for improvement in managing patients with chronic myeloid leukemia: a cross-sectional survey.
Chen, Hong; Zhang, Yuming; Jiang, Yirong; Lin, LiE; Cheng, Shuqin; Xu, Xiaojun; Zhang, Xiong; Lin, Haiqing; Huang, Zhenqian; Wang, Qiang; Zhou, Xuan; Qu, Hong; Liu, Xiaoli; Li, Weiming; Xu, Na.
Afiliación
  • Chen H; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Zhang Y; Department of Hematology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
  • Jiang Y; Department of Hematology, Affiliated Dongguan People's Hospital, Southern Medical University (Dongguan People's Hospital), Dongguan, China.
  • Lin L; Department of Hematology, Hainan General Hospital, Haikou, China.
  • Cheng S; Department of Hematology, Panyu Central Hospital, Guangzhou, China.
  • Xu X; Department of Hematology, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, China.
  • Zhang X; Department of Hematology, Maoming People's Hospital, Maoming, China.
  • Lin H; Department of Hematology, Shenzhen People's Hospital, Second Clinical Medical College of Jinan University, First Affiliated Hospital of Southern University of Science and Technology, Shenzhen, China.
  • Huang Z; Department of Hematology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Wang Q; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Zhou X; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Qu H; Department of Hematology, Panyu Central Hospital, Guangzhou, China.
  • Liu X; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Li W; Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Xu N; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Leuk Lymphoma ; 64(8): 1458-1464, 2023.
Article en En | MEDLINE | ID: mdl-37282611
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Inhibidores de Proteínas Quinasas Tipo de estudio: Evaluation_studies / Guideline / Prevalence_studies / Qualitative_research Límite: Humans Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Inhibidores de Proteínas Quinasas Tipo de estudio: Evaluation_studies / Guideline / Prevalence_studies / Qualitative_research Límite: Humans Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos